Clinical Trials
3 trialsNCT04114136 2026-04-24
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
University of Pittsburgh
Phase 2 Recruiting
NCT02319200 2017-01-11
METFOVIR
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT02672488 2016-02-03
Metformin Plus Sorafenib for Advanced HCC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown